Be part of an influential team who is supporting the development of new treatments for Type 2 diabetes.
The Australian Institute of Tropical Health and Medicine is developing new treatments for Type 2 diabetes. Clinical trials have already explored if parasitic worms, such as hookworms, can protect infected humans from developing Type 2 diabetes by targeting inflammation - a major contributing factor to some metabolic conditions, like Type 2 diabetes.
This project targets these proteins and replicates them in the lab using pharmaceutical industry standards. You will perform research and in vitro screening experiments using human or mouse immune cells to test for hookworm-derived proteins that promote specific cytokine responses as well as using mice to test for hookworm-derived proteins that induce particular immune responses that may be beneficial in Type 2 diabetes.
What you can bring to the role
You will have completed a doctorate degree with a focus on science,
biomedical science, and/or disciplines such as immunology,
biotechnology, endocrinology or cell biology. It is also essential to have experience working with research projects involving the use of pre-clinical models of disease, and downstream analytical techniques such as flow cytometry, qPCR, ELISA or cytometric bead arrays.
Full time, fixed term opportunity to 31 December 2024
Based in tropical North Queensland, Cairns
Academic Level A, Step 50 $82,357 p.a. plus 17% super